Loading...

Autoimmune Hemolytic Anemia as a Complication of Nivolumab Therapy

Recently, immunotherapeutic drugs, including PD-1 inhibitors (nivolumab, pembrolizumab), PD-L1 inhibitors (atezolizumab, avelumab), and CTLA4 inhibitors (ipiliumumab), have emerged as important additions to the armamentarium against certain malignancies and have been incorporated into therapeutic pr...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Case Rep Oncol
Main Authors: Palla, Amruth R., Kennedy, Devin, Mosharraf, Hossain, Doll, Donald
Format: Artigo
Sprog:Inglês
Udgivet: S. Karger AG 2016
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5126613/
https://ncbi.nlm.nih.gov/pubmed/27920704
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000452296
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!